CRBP·21833P103·UQ·equity·Healthcare - Biotechnology-13D/G
CRBP (CORBUS PHARMACEUTICALS HLDGS) is held by 55 institutional investors as of Q4 2025. Largest holders: Aberdeen Group plc ($10.8M), VANGUARD GROUP INC ($7M), CITADEL ADVISORS LLC ($6.9M). Net institutional sentiment: Bullish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer